Adam DuVall to Bridged Bicyclo Compounds, Heterocyclic
This is a "connection" page, showing publications Adam DuVall has written about Bridged Bicyclo Compounds, Heterocyclic.
Connection Strength
0.278
-
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy. Leuk Lymphoma. 2024 Jun; 65(6):864-867.
Score: 0.223
-
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood Cancer J. 2024 02 20; 14(1):32.
Score: 0.056